Literature DB >> 5083313

Significance of azathioprine metabolites.

G B Elion.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5083313      PMCID: PMC1644003     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  8 in total

1.  RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES.

Authors:  G B ELION; S CALLAHAN; R W RUNDLES; G H HITCHINGS
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

2.  The fate of 6-mercaptopurine in mice.

Authors:  G B ELION; S BIEBER; G H HITCHINGS
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

3.  The fate of 6-mercaptopurine in man.

Authors:  L HAMILTON; G B ELION
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

4.  Experimental, clinical, and metabolic studies of thiopurines.

Authors:  E B ELION; S W CALLAHAN; G H HITCHINGS; R W RUNDLES; J LASZLO
Journal:  Cancer Chemother Rep       Date:  1962-02

5.  Serum immunosuppressive activity due to azathioprine and its relation to hepatic function after liver transplantation.

Authors:  C G Mitchell; A L Eddleston; M G Smith; R Williams
Journal:  Lancet       Date:  1970-06-06       Impact factor: 79.321

Review 6.  Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.

Authors:  G B Elion
Journal:  Fed Proc       Date:  1967 May-Jun

7.  In vitro evaluation of immunosuppressive drugs.

Authors:  J F Bach; M Dardenne; C Fournier
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

8.  [Studies on the metabolism of azathioprine].

Authors:  J F Bach; M Dardenne
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1970-07-27
  8 in total
  10 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Liver disease in childhood: principles of management.

Authors:  R Williams
Journal:  Postgrad Med J       Date:  1974-06       Impact factor: 2.401

Review 3.  Problems with immunosuppressive agents in renal disease.

Authors:  J S Cameron
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

Review 4.  Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.

Authors:  D E Drayer
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

5.  Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprine.

Authors:  G Whelan; S Sherlock
Journal:  Gut       Date:  1972-11       Impact factor: 23.059

Review 6.  Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.

Authors:  Alexander Teml; Elke Schaeffeler; Klaus R Herrlinger; Ulrich Klotz; Matthias Schwab
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 5.577

7.  Azathioprine in autologous serum skin test positive chronic urticaria: A case-control study in a tertiary care hospital of eastern India.

Authors:  Dulal Chandra Bhanja; Loknath Ghoshal; Sudip Das; Suchibrata Das; Alok Kumar Roy
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

8.  Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.

Authors:  Sofie Haglund; Svante Vikingsson; Sven Almer; Jan Söderman
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

9.  Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.

Authors:  Christoph Thiel; Henrik Cordes; Isabel Conde; José Vicente Castell; Lars Mathias Blank; Lars Kuepfer
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

10.  Induction of uterine hemangioendothelioma and lymphoma in (C57BL/6N x C3H/2N)F1 mice by oral administration of azathioprine.

Authors:  A Ito; M Mori; M Naito
Journal:  Jpn J Cancer Res       Date:  1989-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.